Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beijing, China (C.J., S.L., Y.W., Y.L., M.Z., L.H., Y.K., X.G., S.L., N.L., C.J., R.T., C.S., D.L., X.D., J.D., C.M.).
DSchool of Clinical Medicine, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, China (Y.B.).
Hypertension. 2023 Mar;80(3):580-589. doi: 10.1161/HYPERTENSIONAHA.122.20112. Epub 2023 Jan 23.
The potential benefits or harms of intensive systolic blood pressure (BP) control on cognitive function and cerebral blood flow in individuals with low diastolic blood pressure (DBP) remain unclear.
We conducted a post hoc analysis of the SPRINT MIND (Systolic Blood Pressure Intervention Trial Memory and Cognition in Decreased Hypertension) that randomly assigned hypertensive participants to an intensive (<120 mm Hg; n=4278) or standard (<140 mm Hg; n=4385) systolic blood pressure target. We evaluated the effects of BP intervention on cognitive outcomes and cerebral blood flow across baseline DBP quartiles.
Participants in the intensive group had a lower incidence rate of probable dementia or mild cognitive impairment than those in the standard group, regardless of DBP quartiles. The hazard ratio of intensive versus standard target for probable dementia or mild cognitive impairment was 0.91 (95% CI, 0.73-1.12) in the lowest DBP quartile and 0.70 (95% CI, 0.48-1.02) in the highest DBP quartile, respectively, with an interaction value of 0.24. Similar results were found for probable dementia (interaction =0.06) and mild cognitive impairment (interaction =0.80). The effect of intensive treatment on cerebral blood flow was not modified by baseline DBP either (interaction =0.25). Even among participants within the lowest DBP quartile, intensive versus standard BP treatment resulted in an increasing trend of annualized change in cerebral blood flow (+0.26 [95% CI, -0.72 to 1.24] mL/[100 g·min]).
Intensive BP control did not appear to have a detrimental effect on cognitive outcomes and cerebral perfusion in patients with low baseline DBP.
URL: https://www.
gov; Unique identifier: NCT01206062.
对于舒张压(DBP)较低的个体,强化收缩压(BP)控制对认知功能和脑血流的潜在益处或危害尚不清楚。
我们对 SPRINT MIND(收缩压干预试验对降低高血压的记忆和认知)进行了事后分析,该研究将高血压参与者随机分配至强化(<120mmHg;n=4278)或标准(<140mmHg;n=4385)收缩压目标组。我们评估了 BP 干预对认知结局和脑血流的影响,结果基于基线 DBP 四分位数。
强化组的痴呆或轻度认知障碍的发生率低于标准组,无论 DBP 四分位数如何。在最低 DBP 四分位数,强化与标准目标的痴呆或轻度认知障碍的危险比为 0.91(95%CI,0.73-1.12),在最高 DBP 四分位数为 0.70(95%CI,0.48-1.02),交互值为 0.24。对于痴呆(交互=0.06)和轻度认知障碍(交互=0.80)也有类似的结果。强化治疗对脑血流的影响也不受基线 DBP 的影响(交互=0.25)。即使在最低 DBP 四分位数的参与者中,强化与标准 BP 治疗也导致脑血流的年化变化呈增加趋势(+0.26[95%CI,-0.72 至 1.24]mL/[100g·min])。
强化 BP 控制似乎对基线 DBP 较低的患者的认知结局和脑灌注没有不良影响。
gov;独特标识符:NCT01206062。